肾
疾病
肾脏疾病
生物
酶
ATP合酶
医学
病理
内科学
生物化学
作者
Xiaoyan Shao,Kai Wang,Jing Wu,Xiaopen Ma,Yinjuan Zhao,Tao Xu,Chunsun Dai,Furong Zhang,Y W Wang,Xianguo Ren,Ke Lu,Zicheng Yin,Baosheng Guo,Changchun Cao,Xianlin Xu,Bin Xue
标识
DOI:10.1096/fj.202400800r
摘要
Abstract Polycystic kidney disease (PKD) is a common hereditary kidney disease. Although PKD occurrence is associated with certain gene mutations, its onset regulatory mechanisms are still not well understood. Here, we first report that the key enzyme geranylgeranyl diphosphate synthase (GGPPS) is specifically expressed in renal tubular epithelial cells of mouse kidneys. We aimed to explore the role of GGPPS in PKD. In this study, we established a Ggpps fl/fl :Cdh16 cre mouse model and compared its phenotype with that of wild‐type mice. A Ggpps ‐downregulation HK2 cell model was also used to further determine the role of GGPPS. We found that GGPPS was specifically expressed in renal tubular epithelial cells of mouse kidneys. Its expression also increased with age. Low GGPPS expression was observed in human ADPKD tissues. In the Ggpps fl/fl :Cdh16 cre mouse model, Ggpps deletion in renal tubular epithelial cells induced the occurrence and development of renal tubule cystic dilation and caused the death of mice after birth due to abnormal renal function. Enhanced proliferation of cyst‐lining epithelial cells was also observed after the knockout of Ggpps . These processes were related to the increased rate of Rheb on membrane/cytoplasm and hyperactivation of mTORC1 signaling. In conclusion, the deficiency of GGPPS in kidney tubules induced the formation of renal cysts. It may play a critical role in PKD pathophysiology. A novel therapeutic strategy could be designed according to this work.
科研通智能强力驱动
Strongly Powered by AbleSci AI